Donald Trump has rescinded an executive order from President Joe Biden that sought to lower the price of drugs.

Many of the 61 million Americans with Medicare are wondering whether their out-of-pocket health costs will be higher in 2025 than in 2024 and, if so, by how much. The answer, like so much about Medicare,

Funding cuts and regulatory changes could radically reduce Medicaid, the largest program providing medical and health-related services to low-income people, as well as Medicare, federal health insurance for people 65 or older, and some under 65 with certain disabilities or conditions.

The Trump administration came into office earlier this week with a promise of cutting down on government spending and driving greater efficiency, but a new poll from KFF shows voters largely support continued spending on Medicare and Medicaid.

As the next round of Medicare drug pricing negotiations get underway, experts predict President Trump may seek to weaken the program.

Individuals in Hawaii have various options for Medicare. These include Original Medicare, Medicare Advantage, and Medicare Part D. Learn more here.

The hugely popular medications Ozempic and Wegovy​, used for diabetes and weight loss, will be included in the next round of talks to negotiate lower Medicare drug prices.

The General Enrollment Period provides an opportunity to make up for a past oversight — the failure to enroll in Part B.

UnitedHealth Group Inc. promoted the head of its Medicare health plan business to lead the company’s broader insurance division, filling the job previously held by slain executive Brian Thompson. Tim Noel,

Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental health conditions. However, they may cover the FDA-approved nasal spray, Spravato, which contains a derivative of ketamine called esketamine.

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.